Tue, October 3, 2017
[ Tue, Oct 03rd 2017 ]: WOPRAI
Farha Aslam Upgraded (CALM) to Buy on, Oct 3rd, 2017
[ Tue, Oct 03rd 2017 ]: WOPRAI
Edwin Mok Upgraded (CAMT) to Strong Buy on, Oct 3rd, 2017
[ Tue, Oct 03rd 2017 ]: WOPRAI
Tiffany Kanaga Downgraded (URBN) to Strong Sell on, Oct 3rd, 2017
[ Tue, Oct 03rd 2017 ]: WOPRAI
James Friedman Downgraded (ACN) to Hold on, Oct 3rd, 2017
[ Tue, Oct 03rd 2017 ]: WOPRAI
Joseph Osha Upgraded (AYI) to Hold on, Oct 3rd, 2017
[ Tue, Oct 03rd 2017 ]: WOPRAI
Krishna Sinha Upgraded (BAH) to Strong Buy on, Oct 3rd, 2017
Mon, October 2, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Brandon Oglenski Maintained (XPO) at Buy with Increased Target to $75 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Brian Nowak Maintained (YELP) at Hold with Increased Target to $40 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Mark May Maintained (YELP) at Strong Buy with Increased Target to $50 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Ravi Shanker Downgraded (CSX) to Sell on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Greg Badishkanian Maintained (THO) at Strong Buy with Increased Target to $146 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Chris Olin Downgraded (STLD) to Hold on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Matthew Harrison Upgraded (SRPT) to Buy on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Philip Cusick Downgraded (UNIT) to Hold on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Ravi Shanker Downgraded (UNP) to Hold on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Benjamin Theurer Maintained (TSN) at Buy with Increased Target to $80 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Robert Moskow Maintained (TSN) at Hold with Increased Target to $75 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Andrew Boone Initiated (TTD) at Buy and Held Target at $7 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Nigel Coe Upgraded (SWK) to Buy on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Christian Schwab Upgraded (STX) to Strong Buy on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Matthew Brooklier Maintained (TRN) at Strong Buy with Increased Target to $36 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Prashant Rao Maintained (TRN) at Strong Buy with Increased Target to $45 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Brian Nowak Upgraded (TRUE) to Hold on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
James Naklicki Maintained (TRV) at Strong Buy with Decreased Target to $140 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Michael Lasser Downgraded (TSCO) to Hold on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Matthew Harrison Downgraded (BLUE) to Sell on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Michael Weinstein Maintained (BKH) at Buy with Increased Target to $77 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Nigel Coe Maintained (WCC) at Buy with Increased Target to $70 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Brandon Oglenski Maintained (WERN) at Hold with Increased Target to $32 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Tristan Gerra Downgraded (WDC) to Hold on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Kaimon Chung Initiated (VIRT) at Hold and Held Target at $17 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Shneur Gershuni Initiated (VNOM) at Hold and Held Target at $18 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Nicholas Yulico Maintained (VTR) at Hold with Decreased Target to $66 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Terence Flynn Upgraded (ALNY) to Strong Buy on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
James Naklicki Maintained (ALL) at Strong Buy with Decreased Target to $106 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Manav Patnaik Maintained (BFAM) at Buy with Increased Target to $90 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
James Naklicki Maintained (AXS) at Hold with Decreased Target to $58 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Brian Meredith Maintained (AXS) at Strong Sell with Decreased Target to $55 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
David Hochstim Initiated (AXP) at Hold and Held Target at $92 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Rajeev Lalwani Maintained (AAL) at Hold with Increased Target to $51 on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
David George Downgraded (ZION) to Sell on, Oct 2nd, 2017
[ Mon, Oct 02nd 2017 ]: WOPRAI
Gregg Moskowitz Downgraded (APPN) to Hold on, Oct 2nd, 2017
Fri, September 29, 2017
[ Fri, Sep 29th 2017 ]: WOPRAI
Chris Kapsch Initiated (AVY) at Hold and Held Target at $99 on, Sep 29th, 2017
[ Fri, Sep 29th 2017 ]: WOPRAI
Prashant Rao Upgraded (TRN) to Strong Buy on, Sep 29th, 2017
[ Fri, Sep 29th 2017 ]: WOPRAI
Bryan Goldberg Downgraded (TSQ) to Sell on, Sep 29th, 2017
[ Fri, Sep 29th 2017 ]: WOPRAI
Laurent Grandet Maintained (TAP) at Hold with Decreased Target to $92 on, Sep 29th, 2017
[ Fri, Sep 29th 2017 ]: WOPRAI
Robin Farley Maintained (WYNN) at Strong Buy with Increased Target to $174 on, Sep 29th, 2017
[ Fri, Sep 29th 2017 ]: WOPRAI
Allison Landry Maintained (XPO) at Buy with Increased Target to $76 on, Sep 29th, 2017

Matthew Harrison Upgraded (SRPT) to Buy on, Oct 2nd, 2017

Matthew Harrison of Morgan Stanley, Upgraded "Sarepta Therapeutics, Inc." (SRPT) to Buy on, Oct 2nd, 2017.

Matthew has made no other calls on SRPT in the last 4 months.



There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Gena Wang of "Barclays" Initiated at Hold and Held Target at $46 on, Thursday, September 7th, 2017


This is the rating of the analyst that currently disagrees with Matthew

  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $81 on, Thursday, September 7th, 2017